Addressing Treatment Challenges
Many untreatable diseases arise from aberrations in multiple pathways, yet most medicines only act on single targets. The creation of medicines that simultaneously act on three or more targets – true multispecifics – has been hampered by a lack of adaptable and easily manufactured biologic platforms that can address disease complexity to this degree. Our team is overcoming these challenges by combining natural protein structures to create unique multispecific antibodies.